Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial. - Motzer RJ; Robbins PB; Powles T; Albiges L; Haanen JB; Larkin J; Mu XJ; Ching KA; Uemura M; Pal SK; Alekseev B; Gravis G; et al. (Nature medicine, 2020)